The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management
Open accessAbstract
In some asthmatic individuals, aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygen-ase 1 (COX-1) exacerbate the condition. This distinct clinical syndrome, called aspirin-induced asthma (AIA), is characterized by an eosinophilic rhinosinusitis, nasal polyposis, aspirin sensitivity, and asthma. There is no in vitro test for the disorder, and diagnosis can be established only by provocation challenges with aspirin or NSAIDs. Recent major advances in the molecular biology of eicosanoids, exemplified by the cloning of 2 cysteinyl leukotriene receptors and the discovery of a whole family of cyclooxygenase enzymes, offer new insights into mechanisms operating in AIA. The disease runs a protracted course even if COX-1 inhibitors are avoided, and the course is often severe, many patients requiring systemic corticosteroids to control their sinusitis and asthma. Aspirin and NSAIDs should be avoided, but highly specific COX-2 inhibitors, known as coxibs, are well tolerated and can be safely used. Aspirin desensitization, followed by daily aspirin treatment, is a valuable therapeutic option in most patients with AIA, particularly those with recurrent nasal polyposis or overdependence on systemic corticosteroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Allergy: Principles and Practice.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-817_10 · Cited by 1,696
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D.-S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965
Intolerance to Aspirin: Clinical Studies and Consideration of its Pathogenesis
SAMTER, M., & BEERS, R. F. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-5-975 · Cited by 839
Hedman, J., Kaprio, J., Poussa, T., & Nieminen, M. M. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.4.717 · Cited by 562
Natural history of aspirin-induced asthma
Szczeklik, A., Niżankowska, E., Duplaga, M., & the Aiane Investigators, O. B. O. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.016003432.x · Cited by 550
Self-citationCowburn, A. S., Sladek, K., Soja, J., Adamek, L., Nizankowska, E., Szczeklik, A., Lam, B. K., Penrose, J. F., Austen, F. K., Holgate, S. T., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci620 · Cited by 550
Self-citationSzczeklik, A., Gryglewski, R. J., & Czerniawska-Mysik, G. (1975) · BMJ · doi:10.1136/bmj.1.5949.67 · Cited by 515
Self-citationSicherer, S. H., Muñoz-Furlong, A., Burks, A. W., & Sampson, H. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70224-1 · Cited by 474
DAHLÉN, B., NIZANKOWSKA, E., SZCZEKLIK, A., ZETTERSTRÖM, O., BOCHENEK, G., KUMLIN, M., MASTALERZ, L., PINIS, G., SWANSON, L. J., BOODHOO, T. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707089 · Cited by 396
Self-citationSousa, A. R., Parikh, A., Scadding, G., Corrigan, C. J., & Lee, T. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013508 · Cited by 373
Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4
Levy, B. D., De Sanctis, G. T., Devchand, P. R., Kim, E., Ackerman, K., Schmidt, B. A., Szczeklik, W., Drazen, J. M., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm748 · Cited by 352
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis
Szczeklik, A., Gryglewski, R. J., & Czerniawska-Mysik, G. (1977) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(77)90106-3 · Cited by 344
Self-citationBerges-Gimeno, M. P., Simon, R. A., & Stevenson, D. D. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.7 · Cited by 333
Self-citationDAHLÉN, S.-E., MALMSTRÖM, K., NIZANKOWSKA, E., DAHLÉN, B., KUNA, P., KOWALSKI, M., LUMRY, W. R., PICADO, C., STEVENSON, D. D., BOUSQUET, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.1.2010080 · Cited by 330
Self-citationLeukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma
Sanak, M., Simon, H.-U., & Szczeklik, A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64015-9 · Cited by 325
Self-citationAspirin-induced asthma: Advances in pathogenesis and management
Szczeklik, A., & Stevenson, D. D. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70106-5 · Cited by 323
Self-citationSestini, P., Armetti, L., Gambaro, G., Pieroni, M. G., Refini, R. M., Sala, A., Vaghi, A., Folco, G. C., Bianco, S., & Robuschi, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564100 · Cited by 259
Bronchoprotective role for endogenous prostaglandin E2
Pavord, I. D., & Tattersfield, A. E. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90409-3 · Cited by 249
Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes
Stevenson, D. D., Sanchez-Borges, M., & Szczeklik, A. (2001) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62221-1 · Cited by 239
Self-citationCyclooxygenase-2 mRNA Is Downexpressed in Nasal Polyps from Aspirin-sensitive Asthmatics
Picado, C., Fernández-Morata, J., Juan, M., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9808048 · Cited by 233
Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication
Zhu, H., Cong, J.-P., Yu, D., Bresnahan, W. A., & Shenk, T. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052713799 · Cited by 229
Tattersfield, A., Knox, A., Britton, Jr., & Hall, I. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11312-2 · Cited by 213
The cyclooxygenase theory of aspirin-induced asthma
Szczeklik, A. (1990) · European Respiratory Journal · doi:10.1183/09031936.93.03050588 · Cited by 210
Self-citationSanak, M., Pierzchalska, M., Bazan-Socha, S., & Szczeklik, A. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.3.4051 · Cited by 202
Self-citationTakasaki, J., Kamohara, M., Matsumoto, M., Saito, T., Sugimoto, T., Ohishi, T., Ishii, H., Ota, T., Nishikawa, T., Kawai, Y., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3140 · Cited by 201
Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma
Stevenson, D. D., & Simon, R. A. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.116290 · Cited by 200
Self-citationKOWALSKI, M. L., Pawliczak, R., Woźniak, J., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9902034 · Cited by 198
Increased Exhaled Cysteinyl-Leukotrienes and 8-Isoprostane in Aspirin-induced Asthma
Antczak, A., Montuschi, P., Kharitonov, S., Gorski, P., & Barnes, P. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2101021 · Cited by 188
Safety of a specific COX‐2 inhibitor in aspirin‐induced asthma
Szczeklik, A., Nizankowska, E., Bochenek, G., Nagraba, K., Mejza, F., & Swierczynska, M. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01075.x · Cited by 187
Self-citationBronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.
Szczeklik, A., Sladek, K., Dworski, R., Nizankowska, E., Soja, J., Sheller, J., & Oates, J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.6.8970343 · Cited by 186
Self-citationWidal, F., Abrami, P., & Lermoyez, J. (1993) · Allergy and Asthma Proceedings · doi:10.2500/108854193778774065 · Cited by 183
Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics
Sanak, M., Levy, B. D., Clish, C. B., Chiang, N., Gronert, K., Mastalerz, L., Serhan, C. N., & Szczeklik, A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16a08.x · Cited by 174
Self-citationVan Sambeek, R., Stevenson, D. D., Baldasaro, M., Lam, B. K., Zhao, J., Yoshida, S., Yandora, C., Drazen, J. M., & Penrose, J. F. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107603 · Cited by 171
Self-citationO’Sullivan, S., Dahlén, B., Dahlén, S.-E., & Kumlin, M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70167-7 · Cited by 163
Bochenek, G., Nagraba, K., Niżankowska, E., & Szczeklik, A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1387 · Cited by 160
Self-citationLeukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma
Kawagishi, Y., Mita, H., Taniguchi, M., Maruyama, M., Oosaki, R., Higashi, N., Kashii, T., Kobayashi, M., & Akiyama, K. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.124466 · Cited by 148
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma
Milewski, M., Mastalerz, L., Niżankowska, E., & Szczeklik, A. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70163-0 · Cited by 146
Self-citationThe prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
Vally, H., Taylor, M. L., & Thompson, P. J. (2002) · Thorax · doi:10.1136/thorax.57.7.569 · Cited by 144
Daffern, P. J., Muilenburg, D. J., Hugli, T. E., & Stevenson, D. D. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70324-6 · Cited by 134
Self-citationPierzchalska, M., Szabó, Z., Sanak, M., Soja, J., & Szczeklik, A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1491 · Cited by 133
Self-citationRagab, S. M., Parikh, A., Darby, Y., & Scadding, G. K. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01160.x · Cited by 122
Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma
Settipane, R. A., & Stevenson, D. D. (1989) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(89)90174-7 · Cited by 117
Self-citationCelecoxib in Patients with Asthma and Aspirin Intolerance
Dahlén, B., Szczeklik, A., & MURRAY, J. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440215 · Cited by 116
Self-citationProtective and Bronchodilator Effects of Prostaglandin E and Salbutamol in Aspirin-Induced Asthma
Szczeklik, A., Mastalerz, L., Nizankowska, E., & Ćmiel, A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564099 · Cited by 107
Self-citationStevenson, D. D., Simon, R. A., Mathison, D. A., & Christiansen, S. C. (2000) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62575-6 · Cited by 92
Self-citationPossible involvement of mast‐cell activation in aspirin provocation of aspirin‐induced asthma
Mita, H., Endoh, S., Kudoh, M., Kawagishi, Y., Kobayashi, M., Taniguchi, M., & Akiyama, K. (2001) · Allergy · doi:10.1111/j.1398-9995.2001.00913.x · Cited by 86
Lazzeri, N., Belvisi, M. G., Patel, H. J., Yacoub, M. H., Chung, K. F., & Mitchell, J. A. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.1.4027 · Cited by 78
Pastorello, E. A., Zara, C., Riario-Sforza, G. G., Pravettoni, V., & Incorvaia, C. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03995.x · Cited by 75
Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps
Mullol, J., Fernández-Morata, J., Roca‐Ferrer, J., Pujols, L., Xaubet, A., Benitez, P. A., & Picado, C. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.123534 · Cited by 69
Aspirin and Salicylates Inhibit the IL-4- and IL-13-Induced Activation of STAT6
Perez-G, M., Melo, M. E. F., Keegan, A. D., & Zamorano, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1428 · Cited by 66
Mastalerz, L., Nizankowska, E., Sanak, M., Mejza, F., Pierzchalska, M., Bazan‐Socha, S., Bestynska‐Krypel, A., Ćmiel, A., & Szczeklik, A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01088.x · Cited by 63
Self-citationOral and inhalation provocation tests for the diagnosis of aspirin‐induced asthma
Melillo, G., Balzano, G., Bianco, S., Dahlén, B., Godard, P., Kowalsky, M. L., Picado, C., Stevenson, D. D., Suetsugu, S., Cheira, C., et al. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.00025.x · Cited by 60
Self-citationMastalerz, L., Milewski, M., Duplaga, M., Nizankowska, E., & Szczeklik, A. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb01248.x · Cited by 60
Self-citationMeans of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance
May, Weber, Gall, Kaufmann, H., & Zollner (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00655.x · Cited by 55
Zhao, J.-L., Austen, K. F., & LAM, B. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8903 · Cited by 52
Bazan, N. G., & Flower, R. (2002) · Nature · doi:10.1038/420135a · Cited by 42
Szczeklik, A., & Sanak, M. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01333.x · Cited by 36
Self-citationSerio, K. J., Hodulik, C. R., & Bigby, T. D. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.2.4042 · Cited by 20
Products of 15‐lipoxygenase: are they important in asthma?
Nasser, S. M., & Lee, T. H. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01529.x · Cited by 15
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
Global strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
“Specific antiCOX-2 enzymes are usually well tolerated in aspirinsensitive patients (149) but many are no longer marketed.”
BackgroundAsthma: defining of the persistent adult phenotypes
Wenzel, S. E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69290-8 · Cited by 1,043
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Metadata
- Authors
- Szczeklik, A., & Stevenson, D. D.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 111
- Issue
- 5
- Pages
- 913-921
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2051808004
- Cited by
- 491
- References
- 61
- FWCI
- 22.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.